EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapy

Ningjing Yang, Peng Zhou, Jiahua Lyu, Jing Ren, Xinyu Nie, Sijia Zhao, Yihong Ye

Nutrition · 2024

DOI: 10.1016/j.nut.2024.112536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, 2024. Verfasst von Ningjing Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengd…. Hauptthemen laut MEDLINE: Sarcopenia, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Muscle, Skeletal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We assessed the impact and prognostic significance of alterations in muscle quality and quantity (myosteatosis and sarcopenia, respectively) in patients with esophageal cancer treated with radiotherapy (RT). METHODS: We retrospectively pooled 258 patients with esophageal squamous cell cancer who underwent RT. Myosteatosis and sarcopenia were determined based on the skeletal muscle index derived from the muscle area and attenuation at the L3 level from computed tomography images. Subgroups were formed as 2 subgroups of non-sarcopenia/myosteatosis and sarcopenia/myosteatosis (with or without other muscle status) at either timepoint of RT, 3 subgroups of only-sarcopenia, only myosteatosis (without other muscle status), and the co-presence of sarcopenia and myosteatosis at either timepoint of RT, as well as 4 subgroups of continuous sarcopenia/myosteatosis, developed sarcopenia/myosteatosis, reduced sarcopenia/myosteatosis and non-sarcopenia/myosteatosis according to alterations of muscle status at both timepoints of RT. Overall survival (OS) was compared. Univariate and multivariate analyses based on Cox regression identified independent risk factors for prognosis. RESULTS: Either pre- or post-RT, patients with sarcopenia and myosteatosis (with or without other muscle status) had poor OS. Patients with only myosteatosis (without other muscle status) showed the best OS (1352 days pre-RT vs. 1648 days post-RT), while patients with concurrent myosteatosis and sarcopenia had the worst OS (907 days pre-RT vs. 706 days post-RT). The ascending order of OS for sarcopenia alterations was as follows: continuous sarcopenia (1093 days), non-sarcopenia (1740 days), developed sarcopenia (2187 days), and reduced sarcopenia (2208 days) (P = 0.002). The ascending order of OS for myosteatosis alterations was ranked as follows: continuous myosteatosis (1165 days), reduced myosteatosis (1275 days), developed myosteatosis (1783 days), and non-myosteatosis (1942 days) (P = 0.061). Univariate and multivariate Cox regression analyses revealed that increased age, longer tumor length, developed myosteatosis, and continuous myosteatosis were independent prognostic factors for OS. CONCLUSIONS: Muscle mass status at presentation and alterations in patients with esophageal cancer before and after RT should be considered prognostic indicators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaMuscle, SkeletalHumansMaleFemaleRetrospective StudiesPrognosisMiddle AgedAgedTomography, X-Ray ComputedCarcinoma, Squamous CellRisk FactorsProportional Hazards Models

Stichwörter der Autor:innen

Computed tomographyRegression analysisRetrospective studiesRisk factorsSkeletal muscle

Autor:innen und Institutionen

  • Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: penghyzhou@126.com.
  • Department of Radiotherapy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.

Zitieren

APA

Yang, N., Zhou, P., Lyu, J., Ren, J., Nie, X., Zhao, S., & Ye, Y. (2024). Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapy. Nutrition. https://doi.org/10.1016/j.nut.2024.112536

Vancouver

Yang N, Zhou P, Lyu J, Ren J, Nie X, Zhao S, et al. Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapy. Nutrition. 2024. doi:10.1016/j.nut.2024.112536

BibTeX
@article{Yang2024,
  author = {Yang, Ningjing and Zhou, Peng and Lyu, Jiahua and Ren, Jing and Nie, Xinyu and Zhao, Sijia and Ye, Yihong},
  title = {Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapy},
  journal = {Nutrition},
  year = {2024},
  doi = {10.1016/j.nut.2024.112536}
}
Kostenlos starten →